Pfizer going 'all in' on obesity drug development, CEO Bourla says
Go back to Pfizer going 'all in' on obesity drug development, CEO Bourla says| Pfizer Inc. (NYSE: PFE) | Delayed: 27.25 +0.38 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.87 | 52 Week High | $37.39 | |||
| Open | $27.15 | 52 Week Low | $28.25 | |||
| Day High | $27.40 | P/E | 16.52 | |||
| Day Low | $27.10 | EPS | $1.65 | |||
| Volume | 34,652,491 | |||||
